首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants
【2h】

Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants

机译:染色质拉伸增强剂状态驱动细胞特异性基因调控并掩盖人类疾病风险变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chromatin-based functional genomic analyses and genomewide association studies (GWASs) together implicate enhancers as critical elements influencing gene expression and risk for common diseases. Here, we performed systematic chromatin and transcriptome profiling in human pancreatic islets. Integrated analysis of islet data with those from nine cell types identified specific and significant enrichment of type 2 diabetes and related quantitative trait GWAS variants in islet enhancers. Our integrated chromatin maps reveal that most enhancers are short (median = 0.8 kb). Each cell type also contains a substantial number of more extended (≥3 kb) enhancers. Interestingly, these stretch enhancers are often tissue-specific and overlap locus control regions, suggesting that they are important chromatin regulatory beacons. Indeed, we show that (i) tissue specificity of enhancers and nearby gene expression increase with enhancer length; (ii) neighborhoods containing stretch enhancers are enriched for important cell type–specific genes; and (iii) GWAS variants associated with traits relevant to a particular cell type are more enriched in stretch enhancers compared with short enhancers. Reporter constructs containing stretch enhancer sequences exhibited tissue-specific activity in cell culture experiments and in transgenic mice. These results suggest that stretch enhancers are critical chromatin elements for coordinating cell type–specific regulatory programs and that sequence variation in stretch enhancers affects risk of major common human diseases.
机译:基于染色质的功能基因组分析和全基因组关联研究(GWAS)共同暗示增强子是影响基因表达和常见疾病风险的关键因素。在这里,我们在人类胰岛中进行了系统的染色质和转录组分析。胰岛数据与来自9种细胞类型的数据的综合分析确定了胰岛增强剂中2型糖尿病和相关定量性状GWAS变体的特异性和显着富集。我们的染色质图谱显示大多数增强子都很短(中位数= 0.8 kb)。每种细胞类型还包含大量更多的扩展(≥3kb)增强子。有趣的是,这些拉伸增强剂通常是组织特异性的和重叠的基因座控制区,表明它们是重要的染色质调节信标。实际上,我们表明(i)增强子的组织特异性和附近基因表达随增强子长度的增加而增加; (ii)含有拉伸增强子的邻域富含重要的细胞类型特异性基因; (iii)与短细胞增强子相比,与特定细胞类型相关性状相关的GWAS变体在拉伸增强子中的含量更高。含有拉伸增强子序列的报道基因构建体在细胞培养实验和转基因小鼠中表现出组织特异性活性。这些结果表明,拉伸增强子是协调细胞类型特异性调节程序的关键染色质元素,并且拉伸增强子的序列变异会影响人类主要常见疾病的风险。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号